iShares JPMorgan USD Emerging Markets Bond ETF vs Revolution Medicines Inc. Common Stock — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.13 (market cap $12.87B), while Revolution Medicines Inc. Common Stock trades at $191 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 3.1× iShares JPMorgan USD Emerging Markets Bond ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, iShares JPMorgan USD Emerging Markets Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares JPMorgan USD Emerging Markets Bond ETF for 51 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| EMB | RVMD | |
|---|---|---|
Market Cap | $12.87B | $40.32B |
Volume | 14,946,002 | 4,855,734 |
Sector | Fixed Income | Health |
52-Week High | $97.74 | $221.15 |
52-Week Low | $90.14 | $47.50 |
Typical Hold Time | 51 Days | 0 Days |
Enterprise Value | — | $37.02B |
Signals from Pluang's Aura AI — not financial advice
EMB trades at $90.96 with minimal daily movement (+0.2%), showing technical bearish signals from moving averages while oscillators remain neutral. The stock faces resistance at $91-92 with support at $90. Recent dividend declarations of $0.41-0.44 per share provide income appeal, though key financial ratios remain undisclosed in current data.
The outlook appears cautious with technical indicators signaling bearish momentum. Income-focused investors may find value in the dividend yield, but limited fundamental data availability and bearish technical signals suggest careful evaluation is warranted. Market risks include broader economic pressures affecting bond yields and emerging market exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →